TDOC Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy

03
Cena $5.63
Kapitalizacja Rynkowa (MRQ) $1.02B
P/E (TTM) -5.7
EPS (TTM) $-0.99
Przychody (TTM) $2.49B
ROE (TTM) -13.0%
Zakres 52 tyg. $4–$10

TDOC Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok

04
zakres
kreski

Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.

O Teladoc Health, Inc. Common Stock Przegląd firmy z Wikipedii

05 · wikidata

Teladoc Health, Inc. is an American telemedicine and virtual healthcare company founded in 2002. Headquartered in New York City, its services include telehealth, employer-sponsored health plans, 24/7 care, mental health, diabetes and hypertension management, primary care, prescriptions, medical opinions, AI and analytics, telehealth devices and licensable platform services.

The company uses telephone and videoconferencing software and mobile apps to provide on-demand remote medical care. Teladoc Health is active in over 175 countries, and is traded on the New York Stock Exchange. It is the first and largest telemedicine company in the United States, and has acquired numerous other companies including BetterHelp in 2015, Best Doctors in 2017, and Catapult Health in 2025.

History

2002–2015

Teladoc was founded in 2002 in Dallas, Texas by G. Byron Brooks and Michael Gorton. It is the oldest and largest telemedicine company in the United States. Teladoc's initial business model allowed patients to remotely consult with state-licensed doctors at any time. Companies paid a monthly fee for their employees to access the service, while patients paid a flat fee for each consultation, originally about $35 to $40. With Gorton as both chairman and CEO, Teladoc launched nationally in 2005 at the Consumer Directed Health Care Conference in Chicago, Illinois. Teladoc had around 1 million members by the end of 2007, with large employers such as AT&T providing the service to employees as a health benefit. Jason Gorevic was named Teladoc's chief executive in 2009. In 2011, Aetna began offering Teladoc for its fully insured members in Florida and Texas, later offering Teladoc in all 50 states.

Teladoc acquired Consult A Doctor for $16.6 million cash in 2013, allowing smaller companies to access Teladoc's services. The Affordable Care Act led to a large number of insurance companies signing with Teladoc, resulting in a growth surge around 2014. By that time, insurance companies such as Blue Shield of California and Oscar had signed with Teladoc, as well as other companies such as Home Depot, T-Mobile, CalPERS, and Rent-A-Center. Teladoc acquired AmeriDoc for $17.2 million in May 2014. The acquisitions of Consult A Doctor and AmeriDoc, both Teladoc's main competitors, resulted in Teladoc becoming the largest telemedicine provider in the United States. After initial fundraising rounds in 2009, 2011, and 2013, Teladoc raised $50 million in 2014, bringing total funding to $100 million. Teladoc's sales doubled in both 2013 and 2014.

2015–2016

Teladoc Health became a public company on July 1, 2015 as the only telemedicine company on the New York Stock Exchange. Teladoc's initial public offering listed at $19 per share, giving the company a market capitalization of $758 million and an enterprise value of $620 million. The initial response to the IPO was positive, as shares surged 50% on the opening day. Three months after the IPO, health insurer Highmark, which represented 1.5% of Teladoc's 2015 revenue, ceased to renew a contract. Teladoc shares fell significantly as a result, before rising to earlier levels. That October, it was the first telehealth company to reach one million visits.

In 2015, Teladoc acquired the behavioral health services provider Compile Inc., operating as BetterHelp for $3.5 million, and competitor Stat Health Services (StatDoc) for $30 million. The following year Teladoc began aggressively expanding, acquiring other companies and launching health segments for dermatology, behavioral health, and sexual health. That year the company won a patent infringement lawsuit filed against competitor American Well.

In July 2016, Teladoc acquired HealthiestYou for $125 million ($45 million in cash and $80 million in stock). Teladoc had 15 million members by November 2016 and a market share of 75% in the United States. The largest national network of virtual care providers in the nation, its full-service suite was operational in 48 states, excluding Arkansas and Texas. In December 2016, the American Hospital Association exclusively endorsed Teladoc's telehealth technology platform. Teladoc logged 952,000 patient visits that year.

2017–2020

In its largest acquisition at the time, in 2017 Teladoc spent $440 million purchasing Best Doctors, a consultation firm and provider of medical second opinions and medical award listings. In 2019, ProPublica criticized companies such as Best Doctors for selling physician awards as pay-to-play. Teladoc had 7,500 clients in 2017, of which 220 were Fortune 1000 companies. Sales that year were $233 million, 89% higher than the year prior. Teladoc Health brands by 2018 included Teladoc, Advance Medical, Best Doctors, BetterHelp and HealthiestYou.

On August 10, 2018, Teladoc, Inc. changed its name to Teladoc Health, Inc. while continuing to trade on the NYSE. Teladoc Health began partnering with CVS in August 2018 on remote consults at MinuteClinics. Teladoc Health acquired Advance Medical, a telemedicine company employing doctors in Latin America, Europe, and Asia, for $352 million in 2018. In December 2018, Teladoc Health's chief financial officer and chief operating officer Mark Hirschhorn resigned after a report that he engaged in a sexual relationship and insider trading with an employee. According to Yahoo Finance, stock value fell roughly 20% in the days following, while an investor class action lawsuit alleged that Teladoc Health had violated securities laws by failing to disclose Hirschhorn's behavior. Teladoc Health denied making false statements or any legal violations.

Active in 130 countries by 2019; that year, Teladoc acquired the French health company MédecinDirect and launched in Canada with the Teladoc Telemedicine Service. Joining from American Express, Mala Murthy was appointed CFO in June 2019.

In March 2020, Teladoc was providing "near real-time" surveillance data on the spread of coronavirus to the CDC. In July 2020, Teladoc acquired InTouch Health. In October 2020, Teladoc acquired the chronic care company Livongo Health for $13.9 billion in a deal described by the press as the third-largest for a U.S. company that year. The combined companies had an estimated enterprise value of $37 billion. Teladoc then brought in Florida Blue as the first insurer to use Livongo's digital diabetes program. Teladoc sued Amwell in October 2020 for alleged copyright infringement on nine patents, settling the case in July 2022.

2021–2024

In early 2021, paid membership in the U.S. was 52 million. In January 2021, Teladoc began offering a diabetes management service through Dexcom. Later that year, Teladoc Health launched myStrength Complete, a "unified mental health care platform for its B2B customers." In June 2021, Teladoc sued the company Avail for allegedly infringing on three patents related to telemedicine consoles.

On July 14, 2021, Teladoc announced it was collaborating with Microsoft to combine its delivery platform for hospitals and health systems with Microsoft Teams. Teladoc introduced its primary care service Primary360 on a national scale in October 2021. The program gave members access to both a primary physician and care team, with a system in place for followup reminders about appointments and personal maintenance. In February 2022, Teladoc Health launched Chronic Care Complete, a program to help patients manage multiple chronic conditions.

Teladoc had a valuation of roughly $11.3 billion by February 2022, and warned investors there might be a goodwill write-down that year related to the Livongo acquisition. Teladoc announced that Amazon could newly access Teladoc through Alexa and related devices, in February 2022, sparking debate among antitrust experts about the potential impact on the health industry. Amazon Care was shut down later that year.

In April 2022, Northwell Health began using the Teladoc platform with its clinicians, starting with 20 hospitals in the system. After Teladoc's stock value fluctuated significantly during the coronavirus pandemic, the company, in June 2022, was sued by investors alleging it had misrepresented its financial prospects, particularly in regard to its BetterHelp mental health subsidiary and chronic care business. Characterizing the lawsuit, which was later dismissed, as "frivolous," in July 2022, Teladoc reported revenue growth above analysts' projections, with significant growth in BetterHelp. In August 2022, Teladoc became the telehealth portal for Mayo Clinic Health System patients in Onalaska, Wisconsin.

In 2023, the company relocated its headquarters to new York City. Charles "Chuck" Divita, III, was appointed CEO in June 2024, leading the company's further expansion. In July, the firm launched Wellbound employee assistance program (EAP), incorporating BetterHelp into its U.S. employer-sponsored health plans.

2025–present

In January 2025, the company added its virtual cardiometabolic programs to Amazon Health Services health benefits connector. That year, Teladoc Health made a series of acquisitions, including Catapult Health in February, mental healthcare company UpLift in April, and Australia's Telecare virtual care firm in August.

In March 2025, the FTC fined BetterHelp $7.8 million for sharing consumer data with third-party social media sites, banning the company from health data disclosures for advertising purposes. Subsequent to the dismissed June 2022 lawsuit, a new class-action was filed by investors in the U.S. District Court for the Southern District of New York on May 17, 2025.

The company reported over 100 million U.S. members in July 2025, and launched new AI capabilities for healthcare workplaces to monitor and mitigate violence that October. In November, Teladoc Health joined with Lumeris, Deloitte, Nuna and Unite Us as Collaborative for Healthy Rural America, pledging to build a shared, integrated care platform, following individual states' plan approvals from the new Rural Health Transformation (RHT) Program of the U.S. Department of Health and Human Services.

Services and business model

Headquartered in New York City, the company operates two main components: Teladoc Health Integrated Care, its virtual care business for health plans, employers and health networks, and BetterHelp direct-to-consumer virtual mental health care. As a technology company, Teladoc Health is involved with artificial intelligence, analytics, telehealth devices, and "licensable platform services." The company uses telephone and videoconferencing software to provide on-demand remote medical care, with patients able to log on to the service at any time and be connected with a board-certified, state-licensed physician. Its app combines all of its services and programs.

Contracting largely with insurers and large employers, hospitals and health systems, Teladoc Health generates revenue through an annual, or monthly, fee charged per subscriber, as well as a fee for individual consults. Some companies waive or subsidize the consult fee for their employees.

By July 2020, the company stated it served "60 of the top 100 hospitals," with telemedical robots being used at hospitals such as Providence Regional Medical Center in Everett, Washington and Sheba Medical Center in Israel, minimizing the potential spread of coronavirus. Numerous studies analyzing Teladoc's impact on the industry have been conducted.

Disaster aid

Teladoc Health provides free telehealth visits to communities affected by federally declared natural disasters and public emergencies in the United States, including to victims of incidents such as the 2018 Camp Fire in Paradise, California, Hurricane Ida in 2021, and the 2025 Southern California wildfires. In March 2023, it began providing free care to residents in Mississippi affected by recent tornadoes and, in 2024, to communities in several states that were impacted by Hurricanes Milton and Helene.

Lobbying and legislation

Teladoc Health has been involved in lobbying for legislation in several states. In 2015 the Texas Medical Board ruled that state physicians had to physically meet patients before remotely treating ailments or prescribing medication. The bill undermined Teladoc Health's business model in Texas, where it had around two million subscribers. Teladoc Health sued in federal court over the rule in Teladoc v. Texas Medical Board, arguing the bill violated antitrust laws by inflating prices and limiting the supply of health care providers in the state. The bill, meant to go active on June 3, 2015, was stalled while the lawsuit went through a federal appeals court, allowing Teladoc Health to continue operating in Texas in the interim. Teladoc voluntarily dropped the lawsuit in 2017 after Texas passed a new bill allowing for remote treatment without a prior in-person interaction, which Teladoc Health had lobbied heavily for.

In January 2019, Teladoc Health opposed a telemedicine bill proposed by the North Dakota Board of Medicine, which required telemedicine providers to perform initial video examinations or have initial exams done by another physician. Proponents argued the bill protected patients, while Teladoc Health and critics argued it decreased access to healthcare in rural areas. The year prior, Teladoc Health had completed 1,500 virtual visits in the state. In May 2019, the company created a virtual care patient safety organization (PSO) dubbed the Institute for Patient Safety and Quality of Virtual Care.

In December 2021, Teladoc along with the American Medical Association, American Hospital Association, AARP, Amazon, Walmart, and CVS formed Telehealth Access for America, a coalition pushing for the extension of telehealth policies implemented by U.S. Congress in response to the COVID-19 pandemic. Subsequently, U.S. Senators Bill Cassidy and Tammy Baldwin introduced the Health Data Use and Privacy Commission Act in February 2022, which proposes creating a commission to study modernizing health data and privacy laws. The proposed legislation was supported by Teladoc and organizations such as the American College of Cardiology, IBM, and the United Spinal Association.

Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗

Wikidata ↗

sektorHealth Care branżaHealth Care pracownicy4 648 krajUS

Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS

06
Przychody$2.53B
2016-12-31 → 2025-12-31
EPS$-1.14
2019-12-31 → 2025-12-31
Wolny przepływ pieniężny$285M
2017-12-31 → 2025-12-31
Marża netto-7.1%
2017-12-31 → 2025-12-31
Wycena i wskaźniki 07–12

Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?

Wskaźnik Trend 5-letni TDOC średnia z 5 lat Mediana porównawcza Werdykt
P/E (TTM) -5.7średnia z 5 lat ≈-11.5 ≈-11.5 · ·
P/S (TTM) 0.4średnia z 5 lat ≈2.3 ≈2.3 2.5 Niedowartościowany
P/B (MRQ) 0.8średnia z 5 lat ≈1.2 ≈1.2 2.9 Niedowartościowany
Cena / FCF (TTM) 4.0średnia z 5 lat ≈24.5 ≈24.5 · ·
Cena / Przepływy pieniężne (TTM) 3.9średnia z 5 lat ≈23.2 ≈23.2 12.7 Niedowartościowany
Cena / Wartość księgowa materialna (MRQ) 7.6 · · ·

Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.

wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany

Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników

14
Średnie zaskoczenie 0.53%
Następny raport Paź 27, 2026
OkresRaportEPS ActualEPS SzacowanyNiespodzianka
30 czerwca 2026 Lip 27, 2026 $-0.21 $-0.25 17.6%
31 marca 2026 $-0.36 $-0.32 -12.6%
31 grudnia 2025 $-0.14 $-0.19 26.9%
30 września 2025 $-0.28 $-0.27 -3.2%
30 czerwca 2025 $-0.19 $-0.27 28.7%
31 marca 2025 $-0.53 $-0.34 -54.2%

Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne

15
Rachunek zysków i strat 18
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Revenue $2.53B$2.57B$2.60B$2.41B$2.03B$1.09B$553M$418M$233M$123M$77M$44M
Cost of Revenue ···$744M$650M$391M$184M$129M$62M$32M$21M$10M
Gross Profit ·······$289M$172M$91M$56M$34M
R&D Expense $278M$307M$349M$334M$312M$165M$65M$54M$34M$22M$14M$8M
SG&A Expense $432M$435M$465M$450M$438M$507M$164M$117M$80M$49M$43M$18M
Operating Expenses $2.79B$3.59B$2.85B$16.06B$2.30B$1.60B$634M$489M$309M···
Operating Income $-263M$-1.02B$-249M$-13.65B$-266M$-506M$-80M$-71M$-75M$-63M$-56M$-15M
Interest Expense ·$24M$22M$22M$81M·······
Interest Income $37M$57M$47M$13M$776.0K·······
Other Non-op $10M$-6M$4M$-859.0K$5M$-545.0K$342.0K·····
Pretax Income $-236M$-994M$-220M$-13.66B$-385M$-576M$-109M$-97M$-107M$-74M$-58M$-17M
Income Tax $-35M$8M$760.0K$-4M$44M$-91M$-11M$118.0K$-225.0K$510.0K$36.0K$388.0K
Net Income $-200M$-1.00B$-220M$-13.66B$-429M$-485M$-99M$-97M$-107M$-74M$-58M$-17M
EPS (Basic) $-1.14$-5.87$-1.34$-84.60$-2.73$-5.36$-1.38·····
EPS (Diluted) $-1.14$-5.87$-1.34$-84.60$-2.73$-5.36$-1.38·····
Shares (Basic) 176,221,530170,564,088164,578,219161,457,123156,939,34990,509,22971,844,535·····
Shares (Diluted) 176,221,530170,564,088164,578,219161,457,123156,939,34990,509,22971,844,535·····
EBITDA $-263M$-1.02B$-249M$-13.40B$-61M$-437M$-80M$-35M$-56M·$-51M·
Bilans 28
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Cash & Equivalents $781M$1.30B$1.12B$918M$893M$733M$514M$424M$43M$50M$55M$46M
Short-term Investments ·······$55M$79M$16M$82M·
Receivables $193M$214M$217M$211M$169M$169M$57M$44M$27M$14M$12M$7M
Inventory $38M$38M$30M$56M$73M$56M$0·····
Prepaid Expense $107M$113M$118M$130M$87M$47M$14M$11M$7M$3M$2M$966.0K
Other Current Assets $2M$3M$7M$12M$6M·······
Current Assets $1.12B$1.66B$1.49B$1.32B$1.23B$1.06B$588M$533M$156M$83M$152M$54M
PP&E (Net) $27M$29M$32M$30M$27M$29M$10M$10M$9M$7M$6M$1M
PP&E (Gross) $112M$101M$92M$77M$61M$51M$26M$22M$17M$12M$8M$2M
Accum. Depreciation $85M$71M$60M$48M$34M$22M$16M$12M$8M$4M$2M$1M
Goodwill $283M$283M$1.07B$1.07B$14.50B$14.58B$746M$737M$499M$188M$56M$28M
Intangibles $1.30B$1.43B$1.68B$1.84B$1.91B$2.02B$225M$247M$160M$25M$15M$8M
Other Non-current Assets $106M$81M$80M$49M$21M$18M$7M$1M$858.0K$415.0K$293.0K$296.0K
Total Assets $2.86B$3.52B$4.39B$4.35B$17.73B$17.76B$1.60B$1.53B$824M$304M$230M$92M
Accounts Payable $48M$33M$44M$48M$47M$46M$9M$8M$4M$2M$2M$2M
Current Liabilities $405M$942M$421M$400M$331M$333M$90M$62M$40M$21M$18M$10M
Capital Leases $34M$32M$43M$38M$42M$43M$25M$0····
Deferred Tax $29M$50M$49M$51M$76M$102M$22M$32M$13M$2M$1M$482.0K
Other Non-current Liabilities $643.0K$720.0K$1M$2M$1M$2M$9M$6M$5M$8M$7M$3M
Total Liabilities $1.47B$2.03B$2.07B·········
Long-term Debt ·········$44M$26M$26M
Total Debt ····$0$43M····$26M·
Common Stock $178.0K$173.0K$167.0K$163.0K$160.0K$150.0K$73.0K$70.0K$61.0K$46.0K$38.0K$2.0K
Retained Earnings $-16.43B$-16.23B$-15.23B$-15.01B$-1.42B$-993M$-508M$-409M$-312M$-205M$-131M$-72M
AOCI $-35M$-38M$-37M$-43M$-6M$19M$-17M$-13M$4M$-1.0K$-42.0K·
Stockholders' Equity $1.39B$1.49B$2.33B$2.31B$16.05B$15.88B$1.01B$1.01B$559M$231M$179M$-68M
Liabilities + Equity $2.86B$3.52B$4.39B$4.35B$17.73B$17.76B$1.60B$1.53B$824M$304M$230M$92M
Shares Outstanding 178,315,400173,405,016166,658,253162,840,360160,469,325150,281,09972,761,94170,516,24961,534,10146,201,56338,524,9222,037,999
Przepływy pieniężne 18
Wskaźnik Trend 202520242023202220212020201920182017201620152014
D&A ···$256M$204M$69M$39M$36M$19M$8M$5M$2M
Stock-based Comp $80M$146M$202M$218M$303M$476M$67M$44M$31M$8M$3M$533.0K
Deferred Tax $-41M$-1M$-2M$-8M$41M$-91M$-11M$-2M$-591.0K$510.0K$36.0K$388.0K
Amort. of Intangibles $351M$363M$326M$245M$195M$65M$36M$32M$15M$6M$4M$2M
Restructuring $19M$20M$17M$7M···$1M····
Other Non-cash ···$13.38B$75M$-23M·$15M$23M·$3M·
Operating Cash Flow $294M$294M$350M$189M$194M$-54M$30M$-5M$-34M$-52M$-47M$-11M
CapEx $9M$11M$11M$16M$9M$4M$4M$4M$3M$2M$6M$1M
Investing Cash Flow $-266M$-124M$-156M$-168M$-73M$-591M$25M$-257M$-448M$26M$-108M·
Debt Issued ·······$10.0K$167M$35M$7M$20M
Net Debt Issued ······$0$10.0K$-60M·$468.0K·
Stock Issued ·····$0$0$331M$259M$250.0K$163M·
Stock Repurchased ···········$368.0K
Net Stock Activity ·····$0$0$331M$259M···
Financing Cash Flow $-552M$8M$11M$6M$41M$859M$35M$646M$475M$21M$164M·
Taxes Paid $9M$9M$7M$3M$4M$1M$1M$441.0K$137.0K···
Free Cash Flow $285M$283M$339M$173M$185M$-58M$26M$-9M$-37M·$-53M·
Levered FCF ·$259M$316M·········
Rentowność 8
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Gross Margin ·······69.2%73.6%·72.8%·
Operating Margin -10.4%-39.7%-9.6%-567.3%-13.1%-46.3%-14.5%-17.0%-32.3%·-72.1%·
Net Margin -7.9%-39.0%-8.5%-567.5%-21.1%-44.4%-17.9%-23.2%-45.8%·-75.0%·
Pretax Margin -9.3%-38.7%-8.4%-567.7%-18.9%-52.6%-19.8%-23.2%-45.9%·-74.9%·
EBITDA Margin -10.4%-39.7%-9.6%-556.6%-3.0%-39.9%-14.5%-8.4%-24.1%·-65.8%·
ROA -6.3%-25.3%-5.0%-123.7%-2.4%-5.0%-6.3%-8.2%-18.9%·-36.1%·
ROE -14.3%-66.8%-9.5%-326.8%-2.7%-5.4%-9.8%-9.5%-27.0%·-104.5%·
ROIC -16.1%-69.0%-10.7%-591.5%-1.8%-2.7%-7.2%-7.0%-13.5%·-27.2%·
Płynność i wypłacalność 5
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Current Ratio 2.81.83.53.33.73.26.58.53.9·8.4·
Quick Ratio 2.41.63.22.83.22.76.38.43.7·8.3·
Debt / Equity ····0.00.0····0.1·
LT Debt / Equity ··········0.1·
Interest Coverage ·-42.9-11.2·········
Efektywność 3
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Asset Turnover 0.80.60.60.20.10.10.40.40.4·0.5·
Inventory Turnover ···11.510.013.8······
Receivables Turnover 12.411.912.212.712.09.711.011.811.4·8.2·
Na akcję 5
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Book Value / Share $7.77$8.60$13.96$14.17$99.99$105.69$13.94$14.37$9.08·$4.63·
Revenue / Share $14.36$15.07$15.81$14.91$12.95·······
Cash Flow / Share $1.67$1.72$2.13$1.17$1.24·······
Cash / Share $4.38$7.49$6.74$5.64$5.57$4.88$7.07$6.01$0.70·$1.43·
EPS (TTM) $-1.14$-5.87$-1.34$-84.60$-2.73$-5.36$-1.38·····
Stopy Wzrostu 3
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Revenue YoY -1.5%-1.3%8.1%18.4%85.8%·······
Revenue CAGR 3Y 1.7%8.1%33.5%·········
Revenue CAGR 5Y 18.3%···········
Wycena (TTM) 13
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Revenue TTM $2.53B$2.57B$2.60B$2.41B$2.03B$1.09B$553M$418M$233M$123M$77M·
Net Income TTM $-200M$-1.00B$-220M$-13.66B$-429M$-485M$-99M$-97M$-107M$-74M$-58M·
Market Cap $1.25B$1.58B$3.59B$3.85B$14.73B$30.05B$6.09B$3.50B$2.14B·$692M·
Enterprise Value ····$13.84B$29.36B····$581M·
P/E -6.1-1.5-16.1-0.3-33.6-37.3-60.7·····
P/S 0.50.61.41.67.227.511.08.49.2·8.9·
P/B 0.91.11.51.70.91.96.03.53.8·3.9·
P / Cash Flow 4.25.410.320.376.0-561.6203.9-719.2-62.3·-14.7·
P / FCF 4.45.610.622.379.4-522.3231.1-394.0-57.8·-12.9·
EV / EBITDA ····-225.4-67.2····-11.4·
EV / FCF ····74.6-510.3····-10.9·
EV / Revenue ····6.826.8····7.5·
Earnings Yield -16.3%-64.6%-6.2%-357.7%-3.0%-2.7%-1.7%·····

Najnowszy okres po lewej · wartości null pokazane jako ·

Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat

16
Wskaźnik 2025-12-312024-12-312023-12-312022-12-312021-12-31
Przychody $2.53B $2.57B $2.60B $2.41B $2.03B
Marża Operacyjna % -10.4% -39.7% -9.6% -567.3% -13.1%
Zysk netto $-200M $-1.00B $-220M $-13.66B $-429M
Rozwodniony EPS $-1.14 $-5.87 $-1.34 $-84.60 $-2.73

Właściciele instytucjonalni (13F) 392 emitenci · $1.5B łącznie · Na dzień 30 września 2026

17

Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.

Posiadacze 392
Wartość posiadanych akcji $1.5B
Nowe pozycje 65
Zamknięte pozycje 34
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
Nowe pozycje Zamknięte pozycje Zwiększone Zmniejszony Zmiana liczby akcji netto
65 (-2 vs poprzedni kw.) 34 (-38 vs poprzedni kw.) 111 (-8 vs poprzedni kw.) 94 (+9 vs poprzedni kw.) +11.8M

Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.

Instytucja Wartość Akcje % z śledzonych 13F Typ
VANGUARD GROUP INC $150 385 949 21 483 707 9,91% Akcje
BlackRock, Inc. $137 572 176 16 223 134 9,07% Akcje
VANGUARD PORTFOLIO MANAGEMENT LLC $107 573 820 12 685 592 7,09% Akcje
Point72 Asset Management, L.P. $69 874 581 8 239 927 4,61% Akcje
RENAISSANCE TECHNOLOGIES LLC $68 457 700 8 072 842 4,51% Akcje
Voss Capital, LP $68 235 838 8 046 679 4,50% Akcje
VANGUARD CAPITAL MANAGEMENT LLC $67 458 671 7 955 032 4,45% Akcje
DIMENSIONAL FUND ADVISORS LP $62 515 646 7 371 699 4,12% Akcje
STATE STREET CORP $42 080 999 4 962 382 2,77% Akcje
AMERICAN CENTURY COMPANIES INC $41 505 394 4 894 504 2,74% Akcje
Allianz Asset Management GmbH $39 572 734 4 666 596 2,61% Akcje
GEODE CAPITAL MANAGEMENT, LLC $39 472 353 4 653 834 2,60% Akcje
GOLDMAN SACHS GROUP INC $32 412 969 3 822 284 2,14% Akcje
Monaco Asset Management SAM $26 864 462 3 167 979 1,77% Akcje
JUPITER ASSET MANAGEMENT LTD $26 370 375 3 109 714 1,74% Akcje
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $25 976 377 3 063 252 1,71% Akcje
Quantinno Capital Management LP $23 904 416 2 818 917 1,58% Akcje
FEDERATED HERMES, INC. $18 037 027 2 127 008 1,19% Akcje
UBS Group AG $17 401 181 2 052 026 1,15% Akcje
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $17 299 632 2 040 051 1,14% Akcje
AMERIPRISE FINANCIAL INC $16 998 584 2 004 550 1,12% Akcje
Pale Fire Capital SE $16 737 502 1 973 762 1,10% Akcje
SUSQUEHANNA INTERNATIONAL GROUP, LLP $16 435 088 1 938 100 1,08% Opcja kupna
NORTHERN TRUST CORP $15 055 374 1 775 398 0,99% Akcje
AQR CAPITAL MANAGEMENT LLC $14 855 924 1 751 878 0,98% Akcje
SUSQUEHANNA INTERNATIONAL GROUP, LLP $11 710 032 1 380 900 0,77% Opcja sprzedaży
BRIDGEWAY CAPITAL MANAGEMENT, LLC $11 348 708 1 338 291 0,75% Akcje
SUSQUEHANNA INTERNATIONAL GROUP, LLP $11 229 479 1 324 231 0,74% Akcje
MORGAN STANLEY $11 055 129 1 303 670 0,73% Akcje
VANGUARD FIDUCIARY TRUST CO $10 120 074 1 193 405 0,67% Akcje
BNP PARIBAS FINANCIAL MARKETS $9 796 800 1 155 283 0,65% Akcje
FRANKLIN RESOURCES INC $9 710 439 1 145 099 0,64% Akcje
Allspring Global Investments Holdings, LLC $9 024 853 991 742 0,59% Akcje
Freestone Grove Partners LP $7 338 160 865 349 0,48% Akcje
Man Group plc $6 880 545 811 385 0,45% Akcje
PRINCIPAL FINANCIAL GROUP INC $6 827 859 805 172 0,45% Akcje
CITADEL ADVISORS LLC $6 795 024 801 300 0,45% Opcja sprzedaży
Union Square Park Capital Management, LLC $6 784 000 800 000 0,45% Akcje
CITADEL ADVISORS LLC $6 532 093 770 294 0,43% Akcje
FMR LLC $6 449 076 760 504 0,43% Akcje
TCW GROUP INC $6 248 039 736 797 0,41% Akcje
Voss Capital, LP $5 936 000 700 000 0,39% Opcja kupna
Empowered Funds, LLC $5 764 619 679 790 0,38% Akcje
Bank of New York Mellon Corp $5 535 043 652 717 0,36% Akcje
D. E. Shaw & Co., Inc. $5 420 493 639 209 0,36% Akcje
PEAK6 LLC $5 227 920 616 500 0,34% Opcja kupna
CITADEL ADVISORS LLC $5 114 288 603 100 0,34% Opcja kupna
Squarepoint Ops LLC $5 089 696 600 200 0,34% Opcja kupna
JANE STREET GROUP, LLC $5 088 848 600 100 0,34% Opcja sprzedaży
JPMORGAN CHASE & CO $4 283 818 484 856 0,28% Akcje

Pokaż wszystkich 392 właścicieli instytucjonalnych →

Aktywiści i właściciele 5%+ 2 akcje

18

Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.

Zgłaszający Złożono Udział Status Cel Zgłoszenie
Kinnevik AB (publ), Invik S.A. ×3 zgłoszenia 15 kwietnia 2021 · Pierwotne zgłoszenie · SEC
General Catalyst Group Management Holdings GP, LLC, General Catalyst Group Management Holdings, L.P., General Catalyst Group Management, LLC, General Catalyst Group VI, L.P., General Catalyst Partners VI, L.P., General Catalyst GP VI, LLC, General Catalyst Group VIII, L.P., General Catalyst Group VIII Supplemental, L.P., General Catalyst Partners VIII, L.P., General Catalyst GP VIII, LLC, GC Partners Holdings, LP, GCSE VIII, L.P., GCSE VIII, LLC, GCGM Investment Holdings, LP, Kenneth I. Chenault, Joel E. Cutler, David P. Fialkow, Hemant Taneja ×3 zgłoszenia 16 marca 2021 · Pierwotne zgłoszenie · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Insiderzy spółki 56 insiderów · 29 dyrektorzy generalni · 24 dyrektorzy

19
Insider Rola Ostatnia aktywność Posiadane akcje Kupna 12m Sprzedaże 12m Netto 12m
Charles Divita III CHIEF EXECUTIVE OFFICER 10 września 2026 M 465 535 0 7 $-1 035 229
Laizer Kornwasser Advisor to the CEO 1 sierpnia 2024 M 99 929 0 0 $0
Jason N Gorevic CHIEF EXECUTIVE OFFICER 19 marca 2024 A 653 073 0 0 $0
Michael F Grasher Chief Financial Officer 1 września 2026 A · 0 0 $0
Mala Murthy CHIEF FINANCIAL OFFICER 29 sierpnia 2025 M 142 385 0 0 $0
Mark Hirschhorn Executive VP, COO and CFO 13 grudnia 2018 M 10 000 0 0 $0
Carlos Nueno President, International 1 września 2026 M 64 744 0 4 $-218 769
Fernando M. Rodrigues President of BetterHelp 1 września 2026 M 0 0 8 $-469 637
Kelly Bliss President, U.S. Group Health 1 września 2026 M 92 832 0 7 $-343 192
Peter A Mcclennen President 15 lipca 2019 M 0 0 0 $0
Michael Willem Waters CHIEF OPERATING OFFICER 30 sierpnia 2024 M 78 309 0 0 $0
David William Sides Chief Operating Officer 29 lipca 2021 M 11 031 0 0 $0
Joseph Ronald Catapano Chief Accounting Officer 1 września 2026 M 12 865 0 6 $-25 521
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY 1 września 2026 M 117 616 0 4 $-289 541
Vidya Raman-Tangella CHIEF MEDICAL OFFICER 4 września 2024 S 33 665 0 0 $0
Andrew Turitz EVP, CORPORATE DEVELOPMENT 4 września 2024 S 20 773 0 0 $0
James L. Cave INTERIM CAO 30 sierpnia 2024 M 13 808 0 0 $0
Nikolaos P. Nanis Chief Technology Officer 30 sierpnia 2024 M 75 410 0 0 $0
Arnnon Geshuri CHIEF PEOPLE OFFICER 30 sierpnia 2024 M 44 914 0 0 $0
Daniel Trencher CHIEF STRATEGY OFFICER 30 sierpnia 2024 M 31 465 0 0 $0
Stephany Verstraete CHIEF MARKETING OFFICER 30 sierpnia 2024 M 48 843 0 0 $0
Richard J Napolitano CHIEF ACCOUNTING OFFICER 19 marca 2024 A 18 077 0 0 $0
Claus Torp Jensen CHIEF INNOVATION OFFICER 1 grudnia 2023 M 20 703 0 0 $0
Lewis Levy Chief Medical Officer 1 października 2020 M 8 766 0 0 $0
Michelle Bucaria Chief Human Resources Officer 1 września 2020 M 3 232 0 0 $0
Christopher Caridi Chief Accounting Officer 1 lipca 2020 A · 0 0 $0
Gabriel R. Cappucci Senior VP, Controller and CAO 16 kwietnia 2020 M 988 0 0 $0
Michael H. King Chief Sales Officer 25 maja 2017 A 61 459 0 0 $0
Peter N. Nieves EVP and CRO 13 marca 2017 A · 0 0 $0
Mark V Anquillare Dyrektor 3 sierpnia 2026 A · 0 0 $0
Catherine Jacobson Dyrektor 21 maja 2026 A 66 853 0 0 $0
Mark Douglas Smith Dyrektor 21 maja 2026 A 8 355 0 0 $0
Kenneth H Paulus Dyrektor 21 maja 2026 A 10 000 1 0 $69 400
David B Snow JR Dyrektor 21 maja 2026 A 113 032 0 0 $0
David L Shedlarz Dyrektor 21 maja 2026 A 61 266 0 0 $0
Susan R Salka Dyrektor 30 marca 2026 A · 0 0 $0
Michael S Smith Dyrektor 18 lutego 2026 A · 0 0 $0
Jason Eric Evans Dyrektor 19 grudnia 2025 M 9 145 0 0 $0
Thomas Mckinley Dyrektor 22 maja 2025 A 56 544 0 0 $0
Karen L Daniel Dyrektor 22 maja 2024 M 36 995 0 0 $0
William H. Frist Dyrektor 26 maja 2022 A 12 918 0 0 $0
Christopher Bischoff Dyrektor 17 maja 2022 M 7 195 0 0 $0
Hemant Taneja Dyrektor 19 kwietnia 2021 S 118 760 0 0 $0
Glen Tullman Dyrektor 1 kwietnia 2021 M 275 793 0 0 $0
Helen Darling Dyrektor 11 czerwca 2020 M 918 0 0 $0
Arneek Multani Dyrektor 30 maja 2019 A 918 0 0 $0
Brian P Mcandrews Dyrektor 30 maja 2019 A 1 965 0 0 $0
Tom Mawhinney Dyrektor 25 maja 2018 M 46 203 0 0 $0
Martin R Felsenthal Dyrektor 8 sierpnia 2016 A 10 860 0 0 $0
Dana G Mead Jr. Dyrektor 8 sierpnia 2016 A 202 0 0 $0
James K Outland Dyrektor 13 lipca 2015 M 49 986 0 0 $0
CHP III Management, L.L.C. Posiadacz 10% 26 kwietnia 2017 J 2 480 468 0 0 $0
CHP III LP Posiadacz 10% 26 kwietnia 2017 J 2 480 468 0 0 $0
Sandra L Fenwick · 21 maja 2026 A 12 070 0 0 $0
Yulun Wang · 25 stycznia 2021 S 219 507 0 0 $0
Michael Goldstein · 11 czerwca 2020 M 0 0 0 $0

Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S

Posiadanie ETF-ów Posiadane przez 37 funduszy ETF

20

Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.

Fundusz Waga Jednostki Na dzień Źródło
IHF · iShares Trust 0,16% 347 966 SH 11 września 2026 Dziennie
VTWV · VANGUARD SCOTTSDALE FUNDS 0,10% 159 976 SH 19 sierpnia 2026 Dziennie
DFSV · Dimensional ETF Trust 0,08% 1 038 485 NS 31 lipca 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0,05% 1 047 849 SH 19 sierpnia 2026 Dziennie
ESML · iShares Trust 0,05% 219 811 SH 11 września 2026 Dziennie
BBSC · J.P. Morgan Exchange-Traded Fund Tr… 0,05% 47 383 NS 31 lipca 2026 N-PORT
VFMF · VANGUARD WELLINGTON FUND 0,04% 29 737 SH 19 sierpnia 2026 Dziennie
RSSL · Global X Funds 0,04% 87 202 NS 31 lipca 2026 N-PORT
IWM · iShares Trust 0,04% 4 676 471 SH 11 września 2026 Dziennie
VBR · VANGUARD INDEX FUNDS 0,03% 2 631 374 SH 19 sierpnia 2026 Dziennie
PNQI · Invesco Exchange-Traded Fund Trust 0,03% 27 091 SH 2 października 2026 Dziennie
DFAT · Dimensional ETF Trust 0,02% 528 876 NS 31 lipca 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0,02% 2 084 219 SH 19 sierpnia 2026 Dziennie
VB · VANGUARD INDEX FUNDS 0,02% 4 153 113 SH 19 sierpnia 2026 Dziennie
VHT · VANGUARD WORLD FUND 0,02% 535 056 SH 19 sierpnia 2026 Dziennie
FHLC · FIDELITY COVINGTON TRUST 0,02% 83 458 NS 31 lipca 2026 N-PORT
DFAS · Dimensional ETF Trust 0,01% 325 784 NS 31 lipca 2026 N-PORT
DXUV · Dimensional ETF Trust 0,01% 11 242 NS 31 lipca 2026 N-PORT
PRF · Invesco Exchange-Traded Fund Trust 0,01% 176 576 SH 2 października 2026 Dziennie
WSML · iShares Trust 0,01% 10 496 SH 11 września 2026 Dziennie
TILT · FlexShares Trust 0,01% 21 330 NS 31 lipca 2026 N-PORT
DFAC · Dimensional ETF Trust 0,01% 449 072 NS 31 lipca 2026 N-PORT
DFSU · Dimensional ETF Trust 0,01% 18 459 NS 31 lipca 2026 N-PORT
DCOR · Dimensional ETF Trust 0,00% 23 195 NS 31 lipca 2026 N-PORT
DSI · iShares Trust 0,00% 25 114 SH 10 września 2026 Dziennie
DFUS · Dimensional ETF Trust 0,00% 82 328 NS 31 lipca 2026 N-PORT
DFAU · Dimensional ETF Trust 0,00% 43 186 NS 31 lipca 2026 N-PORT
ITOT · iShares Trust 0,00% 232 868 SH 11 września 2026 Dziennie
IWV · iShares Trust 0,00% 45 761 SH 3 września 2026 Dziennie
DFUV · Dimensional ETF Trust 0,00% 16 298 NS 31 lipca 2026 N-PORT
VTI · VANGUARD INDEX FUNDS 0,00% 5 687 282 SH 19 sierpnia 2026 Dziennie
VTHR · VANGUARD SCOTTSDALE FUNDS 0,00% 15 175 SH 19 sierpnia 2026 Dziennie
IWN · iShares Trust · 1 697 159 SH 11 września 2026 Dziennie
SVAL · iShares Trust · 100 159 SH 3 września 2026 Dziennie
ISCB · iShares Trust · 7 717 SH 11 września 2026 Dziennie
ISCV · iShares Trust · 38 629 SH 11 września 2026 Dziennie
SMLF · iShares Trust · 597 716 SH 11 września 2026 Dziennie

TDOC Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu

21
ocena · 31 analityków TRZYMAJ
Średni cel $7.50 +33,2%
4 12,9% Mocne kupno
7 22,6% Kup
20 64,5% Trzymaj
0 0,0% Sprzedaj
0 0,0% Mocna sprzedaż

12-miesięczny cel cenowy

17 analityków · 2026-10-02

Średnia cel $7.68 +36,3%

Teraz Aktualna cena $5.63
Niski$5.50 Średnia$7.68 Wysoki$10.50

Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora

22

Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.

Ticker Kapitalizacja Rynkowa P/E Przychody r/r Marża Netto ROE Marża brutto
TDOC $1.25B -6.1 -1.5% -7.9% -14.3% ·
HTFL $2.49B -9.2 39.9% -66.3% 39.3% 76.8%
SDGR · -12.7 23.3% -40.4% -29.2% 55.7%
CERT $1.40B -881.0 8.8% -0.38% -0.15% ·
GDRX · 30.1 0.57% 3.8% 4.8% ·
HSTM $682M 37.8 4.3% 6.0% 5.2% ·
PHR · 335.8 14.5% 0.48% 0.73% ·
CTEV $708M -2.5 3.7% -29.4% 265.9% ·
VEEV $33.40B 37.5 16.3% 28.4% 13.1% 75.5%

Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie

23

Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów

26

Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.

Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.

Źródło: SEC 10-Q złożone Lip 30, 2026